Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 79 entries
Sorted by: Best Match Show Resources per page
Atmosphere-like turbulence generation with surface-etched phase-screens.

Optics express

Hippler S, Hormuth F, Butler DJ, Brandner W, Henning T.
PMID: 19529410
Opt Express. 2006 Oct 30;14(22):10139-48. doi: 10.1364/oe.14.010139.

We built and characterized an optical system that emulates the optical characteristics of an 8m-class telescope like the Very Large Telescope. The system contains rotating glass phase-screens to generate realistic atmosphere-like optical turbulence, as needed for testing multiconjugate adaptive...

Cite
Hippler S, Hormuth F, Butler DJ, et al. Atmosphere-like turbulence generation with surface-etched phase-screens. Opt Express. 2006;14(22):10139-48doi: 10.1364/oe.14.010139.
Hippler, S., Hormuth, F., Butler, D. J., Brandner, W., & Henning, T. (2006). Atmosphere-like turbulence generation with surface-etched phase-screens. Optics express, 14(22), 10139-48. https://doi.org/10.1364/oe.14.010139
Hippler, Stefan, et al. "Atmosphere-like turbulence generation with surface-etched phase-screens." Optics express vol. 14,22 (2006): 10139-48. doi: https://doi.org/10.1364/oe.14.010139
Hippler S, Hormuth F, Butler DJ, Brandner W, Henning T. Atmosphere-like turbulence generation with surface-etched phase-screens. Opt Express. 2006 Oct 30;14(22):10139-48. doi: 10.1364/oe.14.010139. PMID: 19529410.
Copy Download .nbib Format: NLM
Mid-IR femtosecond pulse generation on the microjoule level up to 5 μm at high repetition rates.

Optics letters

Bradler M, Homann C, Riedle E.
PMID: 22048368
Opt Lett. 2011 Nov 01;36(21):4212-4. doi: 10.1364/OL.36.004212.

We show efficient generation of mid-IR pulses tunable between 1 and 5 μm from 100 kHz class femtosecond systems. The concept can be applied to various sources, particularly based on Ti:sapphire and the newly evolving Yb+ lasers. The mid-IR...

Cite
Bradler M, Homann C, Riedle E. Mid-IR femtosecond pulse generation on the microjoule level up to 5 μm at high repetition rates. Opt Lett. 2011;36(21):4212-4doi: 10.1364/OL.36.004212.
Bradler, M., Homann, C., & Riedle, E. (2011). Mid-IR femtosecond pulse generation on the microjoule level up to 5 μm at high repetition rates. Optics letters, 36(21), 4212-4. https://doi.org/10.1364/OL.36.004212
Bradler, Maximilian, et al. "Mid-IR femtosecond pulse generation on the microjoule level up to 5 μm at high repetition rates." Optics letters vol. 36,21 (2011): 4212-4. doi: https://doi.org/10.1364/OL.36.004212
Bradler M, Homann C, Riedle E. Mid-IR femtosecond pulse generation on the microjoule level up to 5 μm at high repetition rates. Opt Lett. 2011 Nov 01;36(21):4212-4. doi: 10.1364/OL.36.004212. PMID: 22048368.
Copy Download .nbib Format: NLM
Immediate β-blockade in patients with myocardial infarctions: is there evidence of benefit?.

Annals of emergency medicine

Sinert R, Newman DH, Brandler E, Paladino L.
PMID: 20493586
Ann Emerg Med. 2010 Nov;56(5):571-7. doi: 10.1016/j.annemergmed.2010.03.036. Epub 2010 May 20.

STUDY OBJECTIVE: The American Heart Association recommends the initiation of β-blockade to all patients with an ST-segment elevation myocardial infarction (STEMI) without contraindications to β-blocking agents. The present study seeks to systematically review the medical literature to determine the...

Cite
Sinert R, Newman DH, Brandler E, et al. Immediate β-blockade in patients with myocardial infarctions: is there evidence of benefit?. Ann Emerg Med. 2010;56(5):571-7doi: 10.1016/j.annemergmed.2010.03.036.
Sinert, R., Newman, D. H., Brandler, E., & Paladino, L. (2010). Immediate β-blockade in patients with myocardial infarctions: is there evidence of benefit?. Annals of emergency medicine, 56(5), 571-7. https://doi.org/10.1016/j.annemergmed.2010.03.036
Sinert, Richard, et al. "Immediate β-blockade in patients with myocardial infarctions: is there evidence of benefit?." Annals of emergency medicine vol. 56,5 (2010): 571-7. doi: https://doi.org/10.1016/j.annemergmed.2010.03.036
Sinert R, Newman DH, Brandler E, Paladino L. Immediate β-blockade in patients with myocardial infarctions: is there evidence of benefit?. Ann Emerg Med. 2010 Nov;56(5):571-7. doi: 10.1016/j.annemergmed.2010.03.036. Epub 2010 May 20. PMID: 20493586.
Copy Download .nbib Format: NLM
Predictive Value of a Genomic Classifier in Indeterminate Thyroid Nodules Based on Nodule Size.

JAMA otolaryngology-- head & neck surgery

Dublin JC, Papazian M, Zan E, Oweity T, Sun W, Jacobson A, Patel K, Brandler TC, Givi B.
PMID: 34734965
JAMA Otolaryngol Head Neck Surg. 2022 Jan 01;148(1):53-60. doi: 10.1001/jamaoto.2021.3080.

IMPORTANCE: Genomic classifiers were developed to better guide clinicians in the treatment of indeterminate thyroid nodules (ITNs). To our knowledge, whether there is variation in the diagnostic accuracy of these tests depending on ITN size has not been previously...

Cite
Dublin JC, Papazian M, Zan E, et al. Predictive Value of a Genomic Classifier in Indeterminate Thyroid Nodules Based on Nodule Size. JAMA Otolaryngol Head Neck Surg. 2022;148(1):53-60doi: 10.1001/jamaoto.2021.3080.
Dublin, J. C., Papazian, M., Zan, E., Oweity, T., Sun, W., Jacobson, A., Patel, K., Brandler, T. C., & Givi, B. (2022). Predictive Value of a Genomic Classifier in Indeterminate Thyroid Nodules Based on Nodule Size. JAMA otolaryngology-- head & neck surgery, 148(1), 53-60. https://doi.org/10.1001/jamaoto.2021.3080
Dublin, Jared C, et al. "Predictive Value of a Genomic Classifier in Indeterminate Thyroid Nodules Based on Nodule Size." JAMA otolaryngology-- head & neck surgery vol. 148,1 (2022): 53-60. doi: https://doi.org/10.1001/jamaoto.2021.3080
Dublin JC, Papazian M, Zan E, Oweity T, Sun W, Jacobson A, Patel K, Brandler TC, Givi B. Predictive Value of a Genomic Classifier in Indeterminate Thyroid Nodules Based on Nodule Size. JAMA Otolaryngol Head Neck Surg. 2022 Jan 01;148(1):53-60. doi: 10.1001/jamaoto.2021.3080. PMID: 34734965; PMCID: PMC8569598.
Copy Download .nbib Format: NLM
The Chronic Lymphocytic Leukemia Comorbidity Index (CLL-CI): A Three-Factor Comorbidity Model.

Clinical cancer research : an official journal of the American Association for Cancer Research

Gordon MJ, Kaempf A, Sitlinger A, Shouse G, Mei M, Brander DM, Salous T, Hill BT, Alqahtani H, Choi M, Churnetski MC, Cohen JB, Stephens DM, Siddiqi T, Rivera X, Persky D, Wisniewski P, Patel K, Shadman M, Park B, Danilov AV.
PMID: 34168050
Clin Cancer Res. 2021 Sep 01;27(17):4814-4824. doi: 10.1158/1078-0432.CCR-20-3993. Epub 2021 Jun 24.

PURPOSE: Comorbid medical conditions define a subset of patients with chronic lymphocytic leukemia (CLL) with poor outcomes. However, which comorbidities are most predictive remains understudied.EXPERIMENTAL DESIGN: We conducted a retrospective analysis from 10 academic centers to ascertain the relative...

Cite
Gordon MJ, Kaempf A, Sitlinger A, et al. The Chronic Lymphocytic Leukemia Comorbidity Index (CLL-CI): A Three-Factor Comorbidity Model. Clin Cancer Res. 2021;27(17):4814-4824doi: 10.1158/1078-0432.CCR-20-3993.
Gordon, M. J., Kaempf, A., Sitlinger, A., Shouse, G., Mei, M., Brander, D. M., Salous, T., Hill, B. T., Alqahtani, H., Choi, M., Churnetski, M. C., Cohen, J. B., Stephens, D. M., Siddiqi, T., Rivera, X., Persky, D., Wisniewski, P., Patel, K., Shadman, M., Park, B., & Danilov, A. V. (2021). The Chronic Lymphocytic Leukemia Comorbidity Index (CLL-CI): A Three-Factor Comorbidity Model. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(17), 4814-4824. https://doi.org/10.1158/1078-0432.CCR-20-3993
Gordon, Max J, et al. "The Chronic Lymphocytic Leukemia Comorbidity Index (CLL-CI): A Three-Factor Comorbidity Model." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,17 (2021): 4814-4824. doi: https://doi.org/10.1158/1078-0432.CCR-20-3993
Gordon MJ, Kaempf A, Sitlinger A, Shouse G, Mei M, Brander DM, Salous T, Hill BT, Alqahtani H, Choi M, Churnetski MC, Cohen JB, Stephens DM, Siddiqi T, Rivera X, Persky D, Wisniewski P, Patel K, Shadman M, Park B, Danilov AV. The Chronic Lymphocytic Leukemia Comorbidity Index (CLL-CI): A Three-Factor Comorbidity Model. Clin Cancer Res. 2021 Sep 01;27(17):4814-4824. doi: 10.1158/1078-0432.CCR-20-3993. Epub 2021 Jun 24. PMID: 34168050; PMCID: PMC8416936.
Copy Download .nbib Format: NLM
A pilot study of high-intensity interval training in older adults with treatment naïve chronic lymphocytic leukemia.

Scientific reports

MacDonald G, Sitlinger A, Deal MA, Hanson ED, Ferraro S, Pieper CF, Weinberg JB, Brander DM, Bartlett DB.
PMID: 34848750
Sci Rep. 2021 Nov 30;11(1):23137. doi: 10.1038/s41598-021-02352-6.

Chronic lymphocytic leukemia (CLL) is the most common leukemia in the USA, affecting predominantly older adults. CLL is characterized by low physical fitness, reduced immunity, and increased risk of secondary malignancies and infections. One approach to improving CLL patients'...

Cite
MacDonald G, Sitlinger A, Deal MA, et al. A pilot study of high-intensity interval training in older adults with treatment naïve chronic lymphocytic leukemia. Sci Rep. 2021;11(1):23137doi: 10.1038/s41598-021-02352-6.
MacDonald, G., Sitlinger, A., Deal, M. A., Hanson, E. D., Ferraro, S., Pieper, C. F., Weinberg, J. B., Brander, D. M., & Bartlett, D. B. (2021). A pilot study of high-intensity interval training in older adults with treatment naïve chronic lymphocytic leukemia. Scientific reports, 11(1), 23137. https://doi.org/10.1038/s41598-021-02352-6
MacDonald, Grace, et al. "A pilot study of high-intensity interval training in older adults with treatment naïve chronic lymphocytic leukemia." Scientific reports vol. 11,1 (2021): 23137. doi: https://doi.org/10.1038/s41598-021-02352-6
MacDonald G, Sitlinger A, Deal MA, Hanson ED, Ferraro S, Pieper CF, Weinberg JB, Brander DM, Bartlett DB. A pilot study of high-intensity interval training in older adults with treatment naïve chronic lymphocytic leukemia. Sci Rep. 2021 Nov 30;11(1):23137. doi: 10.1038/s41598-021-02352-6. PMID: 34848750; PMCID: PMC8633014.
Copy Download .nbib Format: NLM
Gastric glomus tumor diagnosed by fine needle aspiration of the stomach: A report of two cases and review of the literature.

Diagnostic cytopathology

Pizzillo IA, Fang C, Sun W, Brandler TC.
PMID: 34870907
Diagn Cytopathol. 2021 Dec 06; doi: 10.1002/dc.24914. Epub 2021 Dec 06.

Glomus tumors make up 1% of stromal tumors of the stomach. Radiologic diagnosis of glomus tumors can be challenging as they share imaging characteristics with other neuroendocrine tumors and gastrointestinal stromal tumors. Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) has been...

Cite
Pizzillo IA, Fang C, Sun W, et al. Gastric glomus tumor diagnosed by fine needle aspiration of the stomach: A report of two cases and review of the literature. Diagn Cytopathol. 2021;doi: 10.1002/dc.24914.
Pizzillo, I. A., Fang, C., Sun, W., & Brandler, T. C. (2021). Gastric glomus tumor diagnosed by fine needle aspiration of the stomach: A report of two cases and review of the literature. Diagnostic cytopathology, . https://doi.org/10.1002/dc.24914
Pizzillo, Isabella A, et al. "Gastric glomus tumor diagnosed by fine needle aspiration of the stomach: A report of two cases and review of the literature." Diagnostic cytopathology vol. (2021). doi: https://doi.org/10.1002/dc.24914
Pizzillo IA, Fang C, Sun W, Brandler TC. Gastric glomus tumor diagnosed by fine needle aspiration of the stomach: A report of two cases and review of the literature. Diagn Cytopathol. 2021 Dec 06; doi: 10.1002/dc.24914. Epub 2021 Dec 06. PMID: 34870907.
Copy Download .nbib Format: NLM
Efficacy of venetoclax plus rituximab for relapsed CLL: 5-year follow-up of continuous or limited- duration therapy.

Blood

Ma S, Seymour JF, Brander DM, Kipps TJ, Choi MY, Anderson MA, Humphrey K, Al Masud A, Pesko J, Nandam R, Salem AH, Chyla B, Arzt J, Jacobson A, Kim SY, Roberts AW.
PMID: 34115103
Blood. 2021 Sep 09;138(10):836-846. doi: 10.1182/blood.2020009578.

We report long-term follow-up of the phase 1b study of venetoclax and rituximab (VenR) in patients with relapsed chronic lymphocytic leukemia (CLL), including outcomes with continuous or limited-duration therapy. Patients received venetoclax daily (200-600 mg) and rituximab over 6...

Cite
Ma S, Seymour JF, Brander DM, et al. Efficacy of venetoclax plus rituximab for relapsed CLL: 5-year follow-up of continuous or limited- duration therapy. Blood. 2021;138(10):836-846doi: 10.1182/blood.2020009578.
Ma, S., Seymour, J. F., Brander, D. M., Kipps, T. J., Choi, M. Y., Anderson, M. A., Humphrey, K., Al Masud, A., Pesko, J., Nandam, R., Salem, A. H., Chyla, B., Arzt, J., Jacobson, A., Kim, S. Y., & Roberts, A. W. (2021). Efficacy of venetoclax plus rituximab for relapsed CLL: 5-year follow-up of continuous or limited- duration therapy. Blood, 138(10), 836-846. https://doi.org/10.1182/blood.2020009578
Ma, Shuo, et al. "Efficacy of venetoclax plus rituximab for relapsed CLL: 5-year follow-up of continuous or limited- duration therapy." Blood vol. 138,10 (2021): 836-846. doi: https://doi.org/10.1182/blood.2020009578
Ma S, Seymour JF, Brander DM, Kipps TJ, Choi MY, Anderson MA, Humphrey K, Al Masud A, Pesko J, Nandam R, Salem AH, Chyla B, Arzt J, Jacobson A, Kim SY, Roberts AW. Efficacy of venetoclax plus rituximab for relapsed CLL: 5-year follow-up of continuous or limited- duration therapy. Blood. 2021 Sep 09;138(10):836-846. doi: 10.1182/blood.2020009578. PMID: 34115103.
Copy Download .nbib Format: NLM
A Case of Recurrent Hepatic Abscesses.

Gastroenterology

Sheehan JL, Brandler J, Rice MD.
PMID: 33839097
Gastroenterology. 2021 Nov;161(5):1393-1394. doi: 10.1053/j.gastro.2021.04.007. Epub 2021 Apr 08.

No abstract available.

Cite
Sheehan JL, Brandler J, Rice MD. A Case of Recurrent Hepatic Abscesses. Gastroenterology. 2021;161(5):1393-1394doi: 10.1053/j.gastro.2021.04.007.
Sheehan, J. L., Brandler, J., & Rice, M. D. (2021). A Case of Recurrent Hepatic Abscesses. Gastroenterology, 161(5), 1393-1394. https://doi.org/10.1053/j.gastro.2021.04.007
Sheehan, Jessica L, et al. "A Case of Recurrent Hepatic Abscesses." Gastroenterology vol. 161,5 (2021): 1393-1394. doi: https://doi.org/10.1053/j.gastro.2021.04.007
Sheehan JL, Brandler J, Rice MD. A Case of Recurrent Hepatic Abscesses. Gastroenterology. 2021 Nov;161(5):1393-1394. doi: 10.1053/j.gastro.2021.04.007. Epub 2021 Apr 08. PMID: 33839097.
Copy Download .nbib Format: NLM
The ACE (Albumin, CRP and Endoscopy) Index in Acute Colitis: A Simple Clinical Index on Admission that Predicts Outcome in Patients With Acute Ulcerative Colitis.

Inflammatory bowel diseases

Grant RK, Jones GR, Plevris N, Lynch RW, Jenkinson PW, Lees CW, Manship TA, Jagger FAM, Brindle WM, Shivakumar M, Satsangi J, Arnott IDR.
PMID: 32572468
Inflamm Bowel Dis. 2021 Mar 15;27(4):451-457. doi: 10.1093/ibd/izaa088.

BACKGROUND: Intravenous (IV) steroids remain the first-line treatment for patients with acute ulcerative colitis (UC). However, 30% of patients do not respond to steroids, requiring second-line therapy and/or surgery. There are no existing indices that allow physicians to predict...

Cite
Grant RK, Jones GR, Plevris N, et al. The ACE (Albumin, CRP and Endoscopy) Index in Acute Colitis: A Simple Clinical Index on Admission that Predicts Outcome in Patients With Acute Ulcerative Colitis. Inflamm Bowel Dis. 2021;27(4):451-457doi: 10.1093/ibd/izaa088.
Grant, R. K., Jones, G. R., Plevris, N., Lynch, R. W., Jenkinson, P. W., Lees, C. W., Manship, T. A., Jagger, F. A. M., Brindle, W. M., Shivakumar, M., Satsangi, J., & Arnott, I. D. R. (2021). The ACE (Albumin, CRP and Endoscopy) Index in Acute Colitis: A Simple Clinical Index on Admission that Predicts Outcome in Patients With Acute Ulcerative Colitis. Inflammatory bowel diseases, 27(4), 451-457. https://doi.org/10.1093/ibd/izaa088
Grant, Rebecca K, et al. "The ACE (Albumin, CRP and Endoscopy) Index in Acute Colitis: A Simple Clinical Index on Admission that Predicts Outcome in Patients With Acute Ulcerative Colitis." Inflammatory bowel diseases vol. 27,4 (2021): 451-457. doi: https://doi.org/10.1093/ibd/izaa088
Grant RK, Jones GR, Plevris N, Lynch RW, Jenkinson PW, Lees CW, Manship TA, Jagger FAM, Brindle WM, Shivakumar M, Satsangi J, Arnott IDR. The ACE (Albumin, CRP and Endoscopy) Index in Acute Colitis: A Simple Clinical Index on Admission that Predicts Outcome in Patients With Acute Ulcerative Colitis. Inflamm Bowel Dis. 2021 Mar 15;27(4):451-457. doi: 10.1093/ibd/izaa088. PMID: 32572468.
Copy Download .nbib Format: NLM
Erratum: Mwiiri, F.K.; et al. Electrospun Bioactive Wound Dressing Containing Colloidal Dispersions of Birch Bark Dry Extract. .

Pharmaceutics

Mwiiri FK, Brandner JM, Daniels R.
PMID: 33086775
Pharmaceutics. 2020 Oct 19;12(10). doi: 10.3390/pharmaceutics12100991.

The authors wish to make the following correction to this paper [...].

Cite
Mwiiri FK, Brandner JM, Daniels R. Erratum: Mwiiri, F.K.; et al. Electrospun Bioactive Wound Dressing Containing Colloidal Dispersions of Birch Bark Dry Extract. . Pharmaceutics. 2020;12(10)doi: 10.3390/pharmaceutics12100991.
Mwiiri, F. K., Brandner, J. M., & Daniels, R. (2020). Erratum: Mwiiri, F.K.; et al. Electrospun Bioactive Wound Dressing Containing Colloidal Dispersions of Birch Bark Dry Extract. . Pharmaceutics, 12(10), . https://doi.org/10.3390/pharmaceutics12100991
Mwiiri, Francis Kamau, et al. "Erratum: Mwiiri, F.K.; et al. Electrospun Bioactive Wound Dressing Containing Colloidal Dispersions of Birch Bark Dry Extract. ." Pharmaceutics vol. 12,10 (2020). doi: https://doi.org/10.3390/pharmaceutics12100991
Mwiiri FK, Brandner JM, Daniels R. Erratum: Mwiiri, F.K.; et al. Electrospun Bioactive Wound Dressing Containing Colloidal Dispersions of Birch Bark Dry Extract. . Pharmaceutics. 2020 Oct 19;12(10). doi: 10.3390/pharmaceutics12100991. PMID: 33086775; PMCID: PMC7590191.
Copy Download .nbib Format: NLM
Open source, low-cost device for thermometric titration with non-contact temperature measurement.

Talanta

Alessio KO, Tischer B, Voss M, Teixeira ID, Brendler BM, Duarte FA, Helfer GA, Costa AB, Barin JS.
PMID: 32456938
Talanta. 2020 Aug 15;216:120975. doi: 10.1016/j.talanta.2020.120975. Epub 2020 Apr 05.

This work proposes a simple device for thermometric titration using a contactless sensor. A low-cost infrared sensor (around $5) was adapted in a disposable, polystyrene vessel for monitoring the temperature to determine the endpoint of neutralization, redox, and complexation...

Cite
Alessio KO, Tischer B, Voss M, et al. Open source, low-cost device for thermometric titration with non-contact temperature measurement. Talanta. 2020;216:120975doi: 10.1016/j.talanta.2020.120975.
Alessio, K. O., Tischer, B., Voss, M., Teixeira, I. D., Brendler, B. M., Duarte, F. A., Helfer, G. A., Costa, A. B., & Barin, J. S. (2020). Open source, low-cost device for thermometric titration with non-contact temperature measurement. Talanta, 216120975. https://doi.org/10.1016/j.talanta.2020.120975
Alessio, Keiti O, et al. "Open source, low-cost device for thermometric titration with non-contact temperature measurement." Talanta vol. 216 (2020): 120975. doi: https://doi.org/10.1016/j.talanta.2020.120975
Alessio KO, Tischer B, Voss M, Teixeira ID, Brendler BM, Duarte FA, Helfer GA, Costa AB, Barin JS. Open source, low-cost device for thermometric titration with non-contact temperature measurement. Talanta. 2020 Aug 15;216:120975. doi: 10.1016/j.talanta.2020.120975. Epub 2020 Apr 05. PMID: 32456938.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 79 entries